Wird geladen...
Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry
Efavirenz (more specifically the S-enantiomer) is a cornerstone antiretroviral therapy for treatment of HIV infection. The major primary metabolite is S-8-hydroxyefavirenz, which does not have antiretroviral activity but is neurotoxic. Cytochrome P450 2B6 (CYP2B6) is the major enzyme catalyzing S-8-...
Gespeichert in:
| Veröffentlicht in: | Drug Metab Dispos |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6756292/ https://ncbi.nlm.nih.gov/pubmed/31324697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.119.086348 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|